Home/Filings/4/0000899243-20-034308
4//SEC Filing

Krieg Arthur M 4

Accession 0000899243-20-034308

CIK 0001651431other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 5:21 PM ET

Size

9.0 KB

Accession

0000899243-20-034308

Insider Transaction Report

Form 4
Period: 2020-12-15
Krieg Arthur M
Chief Scientific Officer
Transactions
  • Purchase

    Common Stock

    2020-12-16$14.62/sh+4,805$70,249725,444 total
  • Purchase

    Common Stock

    2020-12-15$14.49/sh+42$609720,639 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    68,457
  • Common Stock

    (indirect: See Footnote)
    68,457
  • Common Stock

    (indirect: See Footnote)
    68,457
Footnotes (2)
  • [F1]These shares were purchased in multiple transactions, each at a price of $14.62 per share.
  • [F2]The shares are held by an irrevocable trust for the Reporting Person's child. The Reporting Person serves as trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Issuer

Checkmate Pharmaceuticals, Inc.

CIK 0001651431

Entity typeother

Related Parties

1
  • filerCIK 0001335659

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:21 PM ET
Size
9.0 KB